Home/ Supplements/ Ginkgo/ Cerebrina

Cerebrina

product on market Capsule Sunshine Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 75% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Ginkgo biloba and choline are researched for their roles in supporting cognitive function and neurotransmitter synthesis. However, evidence for the combined efficacy of these ingredients in this specific formulation is limited. The profile maintains a high safety rating with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cerebrina
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
75%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

125 mg
Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
L-Glutamic Acid
125 mg
125 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
125 mg
Within RDA (0.2× RDA) 38 studies (A:1, B:7)

Other Ingredients

Magnesium Stearate Gelatin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Adults take 1 to 3 capsules a day, as a dietary supplement.

Warnings & Precautions

Do not use if safety seal is broken or missing.

Keep out of reach of children.

Formulation Notes

Ginkgo Biloba, L-Glutamic, Inositol and Choline have been used for years to support and restore healthy brain functions.

Proudly Made in the USA.

A natural help to improve memory & brain function

With Ginko Biloba & L-Glutamic

Additional Information

Store in a cool dry place.

Proudly Made in the USA.

Metadata

Product Details

UPC / SKU7 89939 10027 1
DSLD Entry Date2022-07-21
Product TypeOther Combinations
FormCapsule
DSLD ID271170
Data Updated2026-04-11
Research

Research Evidence

183
Research Sources
55
Avg Quality
86
Systematic Review
78
Meta Analysis
7
Other
4
Clinical Trial
2
Rct
2
Narrative Review
2
Regulatory Source
1
Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008 PubMed DOI
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020 PubMed DOI
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Ginkgo →
Compare

Similar Products

View all Ginkgo products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.